USFDA gives approval for Potassium-deficiency drug

"The products will be manufactured at the company's facility in Bengaluru and will be marketed by Strides Pharma Inc. in the US market," the filing said.

258
USFDA Approval
USFDA Approval

Last Updated on October 2, 2024 by The Health Master

New Delhi: Strides Pharma Science Ltd. said that its Singapore-based arm has received approval from the US health regulator for a generic potassium chloride oral solution, used to treat or prevent low amounts of potassium in the blood.

The approval granted by the US Food & Drug Administration (USFDA) to Strides Pharma Global Pte Ltd, Singapore, is for potassium chloride oral solution of strength 40 mEq/15mL (20 percent), Strides Pharma Science (Strides) said in a regulatory filing.

The product is bioequivalent and therapeutically equivalent to Genus Lifesciences Inc.’s reference listed drug (RLD), potassium chloride oral solution USP, 40 mEq/15 mL (20 percent), according to the company.

“The approval further strengthens the potassium chloride franchise for the company, which now comprises extended-release capsules, extended-release tablets, powder for oral solutions, and oral solutions,” Strides said.

The company also has a pipeline of other potassium chloride products, which are expected to be approved and launched in FY24, it said, adding that the entire potassium chloride range of products for the company has a cumulative market opportunity of around USD 330 million as per IQVIA data.

“The products will be manufactured at the company’s facility in Bengaluru and will be marketed by Strides Pharma Inc. in the US market,” the filing said.

USFDA gives final approval for Cyclophosphamide capsules

USFDA gives nod to market this generic Antibiotic Drug

USFDA gives tentative approval for Drospirenone tablets

USFDA approves Ketorolac Tromethamine injection

USFDA gives final approval for Sodium Phenylbutyrate tablets

USFDA gives approval for Glycopyrrolate injection

Govt starts drive against misuse of Antibiotics

Bar code or QR code for 300 brands: Govt notifies these drugs under Schedule H2

USFDA gives EIR to Aurobindo Pharma for its AP facility

Maha FDA to take action against bodybuilders involved in misuse of prescription drugs

Altering the contents of formulation without changing brand names

USFDA issues warning letter to Lupin

Dr VG Somani gets another three-month extension for his post as DCGI

Govt dissolves Odisha State Pharmacy Council

First EC meeting of DCOIWA held at pink city Jaipur

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news